LOGO
  • About
  • Science
  • Patents
  • Academic Program
  • Blog
  • Industry News
  • e·Meditation
  • English
    • English
    • Русский
    • العربية
    • Deutsch
    • Español
    • Français
    • हिन्दी
    • 日本語
    • 한국어
    • Polski
    • Português
    • 简体中文
  1. Home
  2. blog

Home EEG game PainWaive cut neuropathic pain in three of four participants in small UNSW trial

UNSW researchers report that PainWaive, an EEG-based brain-training game, reduced neuropathic pain in three of four people in a four-week home trial. The team used a $300 3D-printed headset and is recruiting larger trials in spinal pain and spinal cord injury.

26 May 2026

Sudoku increased theta and reduced beta in a single-subject consumer‑EEG test

Anastasiia Ku used a BrainBit Mindo headband in a five-session self-experiment (published May 2026) and found increased theta and decreased beta during Sudoku, with most channels returning near baseline after the task.

26 May 2026

The innovation that helped a ballerina with degenerative disease dance again

Dentsu Lab and NTT used a non-invasive EEG headset and machine learning to let Breanna Olson with ALS control a digital avatar and perform live in mixed reality in Amsterdam last December. The work, part of Project Humanity, remains a non-commercial prototype the teams are continuing to train with other users.

26 May 2026

Neurotechnology Industry Trends 2026: BCI, AI, Neuromodulation, Wearable EEG and Neural Data Privacy

For years, the neurotechnology industry was framed as a futuristic field: brain chips, thought-controlled computers, memory implants, mind-reading headsets and science-fiction promises about merging humans with machines. In 2026, the story is different

25 May 2026

MintNeuro signs multi‑year supply deal with Motif Neurotech and markets platform at global meetings

MintNeuro agreed a multi‑year supply deal with Motif Neurotech to provide neural sensing and stimulation chips for Motif's DOT implant, which has FDA clearance to begin a clinical trial in treatment‑resistant depression. The company also promoted its platform this week at the International Neuromodulation Society congress and Deep Tech Momentum 2026.

25 May 2026

Non‑invasive auricular VNS during retrieval boosts recollection for unpleasant images in 75-person study

A University of Potsdam study (N=75) found that non-invasive auricular vagus nerve stimulation during a recognition test selectively increased high-confidence recollection for unpleasant images; overall recognition was unchanged and effects were modest.

25 May 2026

KGMU and IIT Kanpur secure patent for ear-worn vagus nerve stimulator aimed at anxiety and panic

KGMU and IIT Kanpur won a utility patent under the SIB SHInE programme for an ear-worn vagus nerve stimulator aimed at reducing anxiety and managing panic attacks. The device is the third utility patent from SIB SHInE; further patent applications are under examination.

25 May 2026

China reports patient improved from ASIA A to C after combined BCI, spinal stimulation and exoskeleton treatment

Xuanwu Hospital reports a paraplegic patient improved from ASIA A to ASIA C one year after receiving the invasive Beinao No.1 BCI combined with temporally programmed spinal cord stimulation and an exoskeleton. The case, reported by CCTV, describes a single‑patient clinical application performed on May 16, 2025.

23 May 2026

Kordata launches to bring neural recording tech into clinical trial sites

Kordata Dynamics launched from BIOS Health to add neural recording and real‑time dosing tools to hospital trial sites. BIOS retains majority ownership and Emil Hewage will lead the spinout, which targets CNS trials in Alzheimer’s, Parkinson’s and epilepsy.

23 May 2026

Burke Rehab highlights BrainQ trial, Vivistim program and cryoneurolysis during Stroke Awareness Month

Burke Rehabilitation is enrolling patients in the BrainQ EMAGINE trial (NCT06386874), offering an outpatient Vivistim vagus nerve stimulation program, trials of tDCS for aphasia, and cryoneurolysis for spasticity, the hospital’s neurorehabilitation lead said during Stroke Awareness Month.

20 May 2026

Presentation: Intensive, individualized rehab reported to improve function and fatigue in chronic post-stroke disability

A session titled "Intensive Individualized Recovery in Chronic Post-stroke Disability" reported that higher-intensity, personalized rehab produced functional gains and reduced fatigue, and suggested extended neuroplasticity as a mechanism; the source did not provide sample sizes or peer-reviewed results.

20 May 2026

Decoding the Crosstalk Between the Nervous System and Cancer

InteroCANCEption researchers at the Francis Crick Institute report that sensory nerves support tumour growth, that lung tumours remodel nearby nerves, and that cigarette smoke can boost neuronal activity to accelerate tumour progression via a neuro‑immune pathway.

20 May 2026

Organoid intelligence: lab-grown brain tissue explored as low-power computing

Researchers are testing 'organoid intelligence'—computing with lab-grown brain tissue—as a low-power alternative to energy-intensive AI. Early demos (Pong, signal prediction, speech classification) show basic computation, but scalability and performance versus silicon remain unproven.

20 May 2026

Magnetoelectric Backscatter System Improves Wireless Links for Bioelectronic Implants

A 2026 Communications Engineering paper by Alrashdan et al. reports a magnetoelectric backscatter link that reduces implant power use and sustains data transmission through tissue in ex vivo and phantom tests, with ranges from millimetres to several centimetres.

14 May 2026

Frontiers review flags vagus‑targeted neuromodulation as a potential therapy for sepsis‑associated gastrointestinal dysfunction

A 2026 Frontiers in Medicine review frames sepsis‑associated gastrointestinal dysfunction (SAGD) as a neuroimmune and gut–brain disorder and highlights vagus‑targeted neuromodulation, especially taVNS, as a candidate therapy while noting direct clinical evidence is still limited.

14 May 2026

Photobiomodulation: what red‑light therapy does and where the evidence stands

Recent meta‑analyses and reviews support red and near‑infrared photobiomodulation for wound healing, some pain conditions, hair loss and oral mucositis; transcranial uses show early promising signals but lack standardized, long‑term trials.

14 May 2026
← 1 2 3 4 5 6 7 8 9 10 ... 14 15 →

Search

About Us

Stay updated with the latest events and innovations from BrainPatch.ai by following our news and updates!

Categories

  • Announcements
  • Blog
  • Articles
  • Industry News
  • Science News

Archives

  • January 2022
  • January 2024
  • January 2025
  • January 2026
  • February 2023
  • February 2024
  • February 2026
  • March 2023
  • March 2024
  • March 2026
  • April 2025
  • April 2026
  • May 2020
  • May 2022
  • May 2026
  • June 2019
  • June 2022
  • June 2023
  • June 2025
  • June 2026
  • July 2022
  • July 2024
  • July 2025
  • July 2026
  • August 2022
  • August 2025
  • August 2026
  • September 2020
  • September 2024
  • September 2025
  • October 2019
  • October 2021
  • October 2022
  • October 2024
  • October 2025
  • November 2022
  • December 2021
  • December 2022

🍪 We use cookies

We use cookies to enhance your browsing experience and analyze our traffic. Privacy Policy

BrainPatch® and e·Meditation® is a registered trademarks of BrainPatch Ltd.

Follow Us

Site map

  • Home
  • About
  • News
  • Industry News
  • Companies
  • Science
  • Patents
  • Academic Program
  • e·Meditation Device

Follow Us

  • Facebook
  • Instagram
  • LinkedIn
  • X
  • sales@brainpatch.ai
  •  

Contact Us

  • BrainPatch Limited,
    9 Hills Road, CB2 1GE, Cambridge, United Kingdom
    Company Number 11271285
    VAT GB310938419
  • BrainPatch Limited,
    Landscape House, Baldonnell Business Park, Baldonnell, Dublin, D223PK7, Ireland
    Company Number 678405

© 2026 All rights reserved. Created by: BrainPatch Ltd.

Privacy Policy